Related Experiment Video

Updated: Aug 9, 2026

Generation of Human CD40-activated B cells
13:27

Generation of Human CD40-activated B cells

Published on: October 17, 2009

Activation of human B lymphocytes through CD40 and interleukin 4

A Vallé1, C E Zuber, T Defrance

  • 1UNICET Dardilly, France.

European Journal of Immunology
|August 1, 1989
PubMed

Insights

A new CD40 monoclonal antibody, mAb 89, co-stimulates B cell proliferation with anti-IgM antibodies. This antibody activates resting B cells but shows synergy with IL-4, not IL-2, suggesting IL-4 increases CD40 expression for interaction.

Area of Science:

  • Immunology
  • Cell Biology
  • Monoclonal Antibody Technology

Background:

  • CD40 is a crucial co-stimulatory molecule on B cells involved in immune responses.
  • Interleukins (IL-2, IL-4) are key cytokines regulating B cell activation and proliferation.
  • Monoclonal antibodies targeting CD40 are investigated for immunomodulatory therapies.

Purpose of the Study:

  • To characterize a novel CD40 monoclonal antibody, mAb 89, for its ability to modulate B cell activation and proliferation.
  • To investigate the synergistic effects of mAb 89 with IL-2 and IL-4 on B cells.
  • To elucidate the mechanisms underlying the interaction between CD40 signaling and cytokine stimulation.

Main Methods:

  • Production and characterization of anti-CD40 monoclonal antibody (mAb 89).
  • Assessment of B cell activation markers (cell volume) and proliferation assays in response to mAb 89, anti-IgM, IL-2, and IL-4.
  • Flow cytometry analysis of B cell surface receptor expression (IL-4 receptors, CD40 antigen).

Main Results:

  • mAb 89, in combination with anti-IgM, effectively co-stimulates and induces proliferation of resting B cells.
  • mAb 89 activates resting B cells, increasing cell volume and enhancing subsequent anti-IgM-induced proliferation.
  • mAb 89 exhibits synergy with IL-4, but not IL-2, in co-stimulation and restimulation assays, potentially due to IL-4-induced increase in CD40 expression.

Conclusions:

  • The activating properties of anti-CD40 antibodies contribute to their co-stimulatory effects on B cells.
  • The synergistic interaction between IL-4 and anti-CD40 (mAb 89) is linked to IL-4's ability to upregulate CD40 antigen expression on B cells.
  • This study highlights the complex interplay between CD40 signaling and cytokine pathways in regulating B cell responses.

More Related Videos

Murine Model of CD40-activation of B cells12:24

Murine Model of CD40-activation of B cells

Published on: March 6, 2010

Isolation and Activation of Murine Lymphocytes08:08

Isolation and Activation of Murine Lymphocytes

Published on: October 30, 2016

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...